TeraGo Inc. (TRAGF) Financials Oct 14, 2014, 7:10

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
TeraGo Inc. (TRAGF) Financials Oct 14, 2014, 7:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for TeraGo Inc.


Fiscal year is January-December. All values CAD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 34.77M 37.77M 44.92M 49.17M 51.43M
Cost of Goods Sold (COGS) incl. D&A 19.23M 20.09M 18.53M 21.69M 23.57M
COGS excluding D&A 9.09M 9.09M 9.7M 11.02M 11.29M
Depreciation & Amortization Expense 10.14M 11M 8.83M 10.67M 12.28M
Depreciation - 10.51M 7.49M 8.75M 9.73M
Amortization of Intangibles 677,000 493,000 1.34M 1.92M 2.55M
Gross Income 15.54M 17.68M 26.4M 27.48M 27.85M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 22.06M 22.97M 24.62M 23.41M 23.22M
Research & Development - 0 0 0 0
Other SG&A 22.06M 22.97M 24.62M 23.41M 23.22M
Other Operating Expense - 0 0 699,000 0
Unusual Expense 0 0 325,000 0 255,000
EBIT after Unusual Expense 0 0 (325,000) 0 (255,000)
Non Operating Income/Expense 108,000 (270,000) (350,000) (233,000) (265,000)
Non-Operating Interest Income 179,000 32,000 19,000 31,000 36,000
Equity in Affiliates (Pretax) - 0 0 0 0
Interest Expense 2,000 306,000 911,000 828,000 1.13M
Gross Interest Expense 2,000 306,000 911,000 828,000 1.13M
Interest Capitalized - 0 0 0 0
Pretax Income (6.24M) (5.83M) 214,000 2.34M 3.02M
Income Tax 0 0 0 (2.52M) (1.29M)
Income Tax - Current Domestic - 0 0 0 26,000
Income Tax - Current Foreign - 0 0 0 0
Income Tax - Deferred Domestic - 0 0 (2.52M) (1.31M)
Income Tax - Deferred Foreign - 0 0 0 0
Income Tax Credits - 0 0 0 0
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - - - - 0
Consolidated Net Income (6.24M) (5.83M) 214,000 4.86M 4.31M
Minority Interest Expense 0 0 0 0 0
Net Income (6.24M) (5.83M) 214,000 4.86M 4.31M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (6.24M) (5.83M) 214,000 4.86M 4.31M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (6.24M) (5.83M) 214,000 4.86M 4.31M
EPS (Basic) (0.56) (0.52) 0.02 0.43 0.38
Basic Shares Outstanding 11.14M 11.2M 11.27M 11.32M 11.42M
EPS (Diluted) (0.56) (0.52) 0.02 0.41 0.36
Diluted Shares Outstanding 11.14M 11.2M 12.78M 11.84M 11.81M
EBITDA 3.62M 5.71M 10.61M 14.04M 16.91M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 130

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 278

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 132

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 187

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 131

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 184

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 166

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Aescape Expands into Miami with Privai Spa Partnership

Updated Category News Views 160

Aescape Expands into Miami with Privai Spa Partnership In a thrilling development for luxury wellness, Aescape, known for its automated massage innovations, has teamed up with Privai Spa + Fitness to introduce its services at the famous Kimpton EPIC Hotel in Miami. This exciting collaboration features a fully customizable robotic massage experience that integrates...

Continue Reading
Debating Crypto Regulations: A Look at Elected Officials' Influence

Updated Category News Views 120

Democrats Seek Enhanced Crypto Regulations In recent discussions surrounding the cryptocurrency market structure bill, leading Democrats have expressed a clear intent to impose stricter regulations, particularly concerning stablecoin yield payments. Their aim is to mitigate any potential risks linked to elected officials’ cryptocurrency ventures. This initiative...

Continue Reading
Investors’ Chance to Lead PACS Group Inc. Securities Case

Updated Category News Views 170

Opportunity for Investors in PACS Group Inc. Investors in PACS Group Inc. (NYSE: PACS) are faced with a significant opportunity to join forces in a legal battle against alleged securities fraud. The Rosen Law Firm, recognized for its commitment to investor rights, has announced to all shareholders who acquired PACS common stock that they may now have a chance to seek...

Continue Reading
AvAir Grows Its Inventory with New Wheels and Brakes

Updated Category News Views 116

AvAir Expands Its Inventory with Lufthansa Technik Components New Inventory Includes 1,600 Wheel and Brake Assemblies AvAir, a prominent player in the aviation aftermarket sector, has significantly boosted its inventory by acquiring over 1,600 overhauled wheels and brakes from Lufthansa Technik's spare parts pool. This acquisition builds upon the long-standing...

Continue Reading
Versapay Welcomes Elizabeth Bramlage as New Marketing Leader

Updated Category News Views 323

Versapay Appoints Elizabeth Bramlage as Chief Marketing Officer Versapay has announced the appointment of Elizabeth Bramlage as the new Chief Marketing Officer, aiming to strengthen brand growth and expand its market presence. With a wealth of experience in the fintech and payments landscape, Elizabeth’s leadership will be vital in driving the company's marketing...

Continue Reading